Brendan Smith
Stock Analyst at TD Cowen
(4.68)
# 796
Out of 4,609 analysts
276
Total ratings
55.9%
Success rate
18.2%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZTA Azenta | Maintained: Hold | $20 → $33 | $30.75 | +7.33% | 12 | Aug 5, 2026 | |
| SDGR Schrödinger | Maintained: Buy | $20 | $17.82 | +12.23% | 12 | Aug 5, 2026 | |
| ABCL AbCellera Biologics | Maintained: Buy | n/a | $6.22 | - | 11 | Aug 5, 2026 | |
| RXRX Recursion Pharmaceuticals | Maintained: Hold | n/a | $3.17 | - | 11 | Aug 5, 2026 | |
| TKNO Alpha Teknova | Reiterated: Buy | $7 | $6.29 | +11.29% | 12 | Aug 5, 2026 | |
| CTKB Cytek Biosciences | Maintained: Hold | $5 | $4.18 | +19.76% | 12 | Aug 5, 2026 | |
| CERT Certara | Maintained: Buy | $9 | $8.03 | +12.08% | 10 | Aug 4, 2026 | |
| TWST Twist Bioscience | Rated: Buy | $89 → $115 | $111.94 | +2.73% | 18 | Aug 3, 2026 | |
| RGEN Repligen | Maintained: Buy | $200 | $162.09 | +23.39% | 11 | Jul 28, 2026 | |
| WST West Pharmaceutical Services | Rated: Buy | $410 | $349.69 | +17.25% | 7 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 → $31 | $34.28 | -9.57% | 12 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $2 | $1.96 | +2.04% | 10 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 | $28.81 | -93.06% | 1 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $18.32 | -12.67% | 5 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.13 | - | 7 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.12 | - | 11 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.45 | - | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $96 | $83.04 | +15.61% | 23 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $1.46 | +36.99% | 10 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $8.71 | +37.77% | 13 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.48 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $2.16 | +39.21% | 10 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.43 | - | 10 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $86.44 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.45 | n/a | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $9 | $7.68 | n/a | 6 | Nov 12, 2024 |
Azenta
Aug 5, 2026
Maintained: Hold
Price Target: $20 → $33
Current: $30.75
Upside: +7.33%
Schrödinger
Aug 5, 2026
Maintained: Buy
Price Target: $20
Current: $17.82
Upside: +12.23%
AbCellera Biologics
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $6.22
Upside: -
Recursion Pharmaceuticals
Aug 5, 2026
Maintained: Hold
Price Target: n/a
Current: $3.17
Upside: -
Alpha Teknova
Aug 5, 2026
Reiterated: Buy
Price Target: $7
Current: $6.29
Upside: +11.29%
Cytek Biosciences
Aug 5, 2026
Maintained: Hold
Price Target: $5
Current: $4.18
Upside: +19.76%
Certara
Aug 4, 2026
Maintained: Buy
Price Target: $9
Current: $8.03
Upside: +12.08%
Twist Bioscience
Aug 3, 2026
Rated: Buy
Price Target: $89 → $115
Current: $111.94
Upside: +2.73%
Repligen
Jul 28, 2026
Maintained: Buy
Price Target: $200
Current: $162.09
Upside: +23.39%
West Pharmaceutical Services
Jul 23, 2026
Rated: Buy
Price Target: $410
Current: $349.69
Upside: +17.25%
Jul 23, 2026
Downgraded: Hold
Price Target: $33 → $31
Current: $34.28
Upside: -9.57%
Jul 15, 2026
Downgraded: Hold
Price Target: $4 → $2
Current: $1.96
Upside: +2.04%
Jul 14, 2026
Downgraded: Hold
Price Target: $2
Current: $28.81
Upside: -93.06%
Jul 9, 2026
Maintained: Hold
Price Target: $16
Current: $18.32
Upside: -12.67%
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $2.13
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $1.12
Upside: -
May 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.45
Upside: -
May 11, 2026
Maintained: Buy
Price Target: $96
Current: $83.04
Upside: +15.61%
May 7, 2026
Maintained: Hold
Price Target: $2
Current: $1.46
Upside: +36.99%
May 7, 2026
Maintained: Buy
Price Target: $12
Current: $8.71
Upside: +37.77%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $8.48
Upside: -
May 7, 2026
Maintained: Buy
Price Target: $3
Current: $2.16
Upside: +39.21%
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $8.43
Upside: -
May 13, 2025
Maintained: Buy
Price Target: n/a
Current: $86.44
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: n/a
Current: $24.45
Upside: n/a
Nov 12, 2024
Maintained: Hold
Price Target: $14 → $9
Current: $7.68
Upside: n/a